Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma

Figure 5

Effects of miR-221/222 on tumor growth in a xenograft mouse model. (A) After establishment of subcutaneous tumors, As-miR-221/222 and miR-221/222 were injected in a multi-site injection manner every 3 days for 15 days. Tumor volumes were measured every 2 days during treatment. (B) Expression of TIMP3, MMP2 and MMP9 was detected by immunohistochemistry in xenograft tumor sections.

Back to article page